• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.

作者信息

Breyer S, Georgopoulos A, Graninger W

机构信息

Department of Chemotherapy, School of Medicine, University of Vienna, Austria.

出版信息

Drugs Exp Clin Res. 1987;13(8):479-81.

PMID:2962843
Abstract

In vitro activities of teicoplanin were compared with those of ampicillin, imipenem, rifampicin, coumermycin and vancomycin against clinical isolates of Streptococcus faecalis (n = 100) and Streptococcus faecium (n = 30). Against Str. faecalis, ampicillin and imipenem had an MIC90 and MBC90 of 3.9 micrograms/ml. Coumermycin and rifampicin had poor bactericidal activity with MBC90 values of 31.2 and 62.5 micrograms/ml. Teicoplanin was extremely active with an MIC90 of 0.95 microgram/ml and an MBC90 of 1.86 micrograms/ml.

摘要

相似文献

1
In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
Drugs Exp Clin Res. 1987;13(8):479-81.
2
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
J Antimicrob Chemother. 1985 Aug;16(2):179-82. doi: 10.1093/jac/16.2.179.
3
[The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].替考拉宁和万古霉素对革兰氏阳性微生物的体外活性(校正后)
Mikrobiyol Bul. 1991 Oct;25(4):321-5.
4
Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.肠球菌的敏感性。一、几种化学抗生素对粪链球菌和屎肠球菌的抑制及杀菌活性。
Chemioterapia. 1986 Oct;5(5):302-8.
5
In vitro activity of the new glycopeptide decaplanin.
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62. doi: 10.1007/BF01961864.
6
Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Chemioterapia. 1988 Feb;7(1):20-3.
7
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
8
Susceptibility of enterococci. II. Inhibitory and bactericidal activity of drugs in combination against Streptococcus faecalis and Streptococcus faecium.肠球菌的敏感性。II. 药物联合对粪链球菌和屎肠球菌的抑制及杀菌活性。
Chemioterapia. 1986 Oct;5(5):309-12.
9
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.亚胺培南(N-甲酰亚胺基硫霉素)对肠球菌的比较活性及其与氨基糖苷类药物的相互作用。
J Antimicrob Chemother. 1984 Feb;13(2):129-32. doi: 10.1093/jac/13.2.129.
10
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.台湾地区达托霉素、糖肽类、利奈唑胺和替加环素对革兰氏阳性菌血液分离株的杀菌活性比较
Clin Microbiol Infect. 2008 Feb;14(2):124-9. doi: 10.1111/j.1469-0691.2007.01888.x. Epub 2007 Dec 10.

引用本文的文献

1
Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Infection. 1989 May-Jun;17(3):177-81. doi: 10.1007/BF01644026.
2
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.替考拉宁:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1990 Sep;40(3):449-86. doi: 10.2165/00003495-199040030-00007.